IM Cannabis (IMCC) Gains from Equity Investments (2020 - 2026)

IM Cannabis' Gains from Equity Investments history runs 7 years deep, the most recent figure standing at -$313558.4 for Q1 2026.

• In Q1 2026, Gains from Equity Investments fell 113.05% year-over-year to -$313558.4; the TTM figure through Mar 2026 stood at $8.9 million (down 9.61% YoY), while the FY2024 annual figure was $6.2 million, down 23.1% from the prior year.
• Gains from Equity Investments for Q1 2026 stood at -$313558.4, down from $2.4 million in the prior quarter.
• The five-year high for Gains from Equity Investments was $4.4 million in Q4 2024, with the low at -$313558.4 in Q1 2026.
• The 5-year median for Gains from Equity Investments is $2.2 million (2024), against an average of $2.1 million.
• The sharpest annual moves came in 2022 and 2026: Gains from Equity Investments jumped 315.6% in 2022, then sank 113.05% in 2026.
• IM Cannabis' Gains from Equity Investments stood at $2.1 million in 2022, then soared by 45.08% to $3.0 million in 2023, then surged by 49.12% to $4.4 million in 2024, then sank by 45.98% to $2.4 million in 2025, then tumbled by 113.05% to -$313558.4 in 2026.
• Business Quant data shows IMCC's Gains from Equity Investments at -$313558.4 in Q1 2026, $2.4 million in Q1 2025, and $4.4 million in Q4 2024.